Cargando…

Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers

Heart failure is a complex syndrome affecting several organs including kidney, lungs, liver, brain muscles and sympathetic system. Each of these organs might contribute to its severity and prognosis. The prognosis assessment is critical for a correct heart failure management. It has already been dem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cattadori, Gaia, Di Marco, Silvia, Farina, Stefania, Limongelli, Giuseppe, Monda, Emanuele, Badagliacca, Roberto, Papa, Silvia, Tricarico, Lucia, Correale, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Full Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691627/ https://www.ncbi.nlm.nih.gov/pubmed/33238743 http://dx.doi.org/10.1177/2047487320951109

Ejemplares similares

Future developments in the MECKI score initiative
por: Coats, Andrew JS
Publicado: (2020)

The MECKI score initiative: Development and state of the art
por: Salvioni, Elisabetta, et al.
Publicado: (2020)

The MECKI score initiative: a successful and ongoing story
por: Piepoli, Massimo F, et al.
Publicado: (2020)

The double anaerobic threshold in heart failure: MECKI score database overview
por: Rovai, Sara, et al.
Publicado: (2022)

Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients
por: Kouwert, Ilse JM, et al.
Publicado: (2019)

The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
por: Farina, Stefania, et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Editorial: Paediatric Cardiomyopathies
por: Monda, Emanuele, et al.
Publicado: (2021)

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy
por: Monda, Emanuele, et al.
Publicado: (2023)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension
por: Pezzuto, B., et al.
Publicado: (2022)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

It’s Time to Run!
por: Cattadori, Gaia, et al.
Publicado: (2023)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

Beta-Blockers and Cancer: Where Are We?
por: Peixoto, Rita, et al.
Publicado: (2020)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers
por: Cojocariu, Sabina Alexandra, et al.
Publicado: (2021)

Topical beta‐blockers in dermatologic therapy
por: Filoni, Angela, et al.
Publicado: (2021)

Discovery and Characterization of Multiple Classes of Human CatSper Blockers
por: Carlson, Erick J., et al.
Publicado: (2022)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
por: Masarone, Daniele, et al.
Publicado: (2019)

Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study)
por: Glezer, Maria, et al.
Publicado: (2018)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

The evaluation of beta blocker and calcium antagonist drugs
Publicado: (1982)

Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
por: Fitzgerald, Paul J
Publicado: (2012)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017)

Clinical Impact of Beta-blockers in the Revascularization Era
por: Kang, Soo-Jin
Publicado: (2020)

Oral Beta-blocker in Problematic Infantile Hemangioma
por: AlHasan, Rashed N., et al.
Publicado: (2021)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Effect of Beta-blockers on Extracranial Arteriovenous Malformations
por: CHASTANET, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jeern8r2h75frp7fhg964hhtri